Introduction
Angiotensin II is a potent vasoconstrictor hormone, which is cleaved from angiotensinogen by renin and angiotensin-converting enzyme (ACE). In addition to its known vital role in both cardiovascular and fluid homeostasis, several lines of evidence implicate angiotensin II in the ischemic neuronal injury via the angiotensin II receptor subtype AT1 (AT1R) (Walter et al., 2002) . Emerging evidences suggest that peripherally administered AT1R blockers (ARBs) can interact with AT1R in the brain across the blood-brain barrier (BBB) and reduce the infarct volumes in the experimental cerebral ischemia model (Dai et al., 1999; Nishimura et al., 2000; Yamakawa et al., 2003) . Recently, ARBs were also proven to attenuate the inflammatory and oxidative stress (Ando et al., 2004; Zhou et al., 2005) and regulate the NOS isoenzymes in the brain (Ito et al, 2002) . As a potent and highly selective AT1 receptor antagonist, telmisartan is described chemically as 4 [(1,4-dimethyl-2-propyl(2,6-bi-1H- benzimidazol]-1-yl)methyl] [1,1-biphenyl]-2-carboxylic acid. This unique feature of telmisartan accounts for both its high receptor affinity and its excellent pharmacokinetic properties. Furthermore, telmisartan could confer effects other than the blockage of the AT1R, such as peroxisome proliferator-activated receptor-γ (PPAR-γ) activation (Benson et al., 2004) . This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on May 30, 2007 as DOI: 10.1124 at ASPET Journals on January 16, 2020 jpet.aspetjournals.org The neurotoxicity associated with intracerebral hemorrhage (ICH) includes inflammation, oxidative stress, excitotoxicity, as well as toxic effects of blood degradation products (Wang et al., 2002; Chu et al., 2004; Jung et al., 2004; Lee et al., 2006) . Recent works have indicated that the suppression of these responses can reduce the brain edema and improve functional outcomes in experimental ICH (Mayne et al., 2001; Peeling et al., 2001; Chu et al., 2004; Jung et al., 2004; Lee et al., 2006) . Given that angiotensin II is the principal inducer of oxidative stress and inflammation (Rajagopalan et al., 1996; Iadecola et al., 2004; Chalupsky and Cai., 2005) , the acute blockade of AT1R might exert beneficial effects in the hemorrhagic brain. However, to date, there was no study validating the effects of ARB as a potential therapeutic agent against ICH.
Peripherally administered telmisartan penetrates the BBB to inhibit the central effects of angiotensin II, via selective blockage of AT1R, but not AT2R (Gohlke et al., 2001 ). Since high doses of the antagonist, i.e. 10 mg/kg i.v. and 30 mg/kg p.o., could result in the nearly complete and sustained blockade of AT1R within the brain (Gohlke et al., 2001) , we attempted to study the therapeutic effects of a high dose of telmisartan in normotensive rats in which ICH had been induced.
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METHODS
Induction of intracerebral hemorrhage and telmisartan treatment
All the procedures were performed following an institutional approval in accordance with NIH Guide for the Care and Use of Laboratory Animals. Male Sprague-Dawley rats (12 weeks old; Orient, Seoul, Republic of Korea), weighing 200-220 gm, were randomly assigned to two experimental groups: ICH-vehicle group (ICH-only), and telmisartan-treated ICH group (ICH-TMS). Experimental ICH was induced via stereotaxic intrastriatal administration of bacterial collagenase type VII (Sigma), as has been described in other reports (Chu et al., 2004; Jung et al., 2004; Lee et al., 2006) .
Two hours after ICH induction, single oral dose of telmisartan (30 mg/kg/dose, p.o.;
GSK, Korea; dissolved in 1 mL of PBS) was administered to the rats by feeding tubes.
An equal amount of PBS was administered to the ICH-only group. We measured mean arterial blood pressure and arterial blood gases via a right femoral artery line (P.E.50 tubing). A small amount of heparinized saline was used to prevent clotting in the femoral artery and catheter. Physiological parameters were assessed 30 minutes before and after ICH induction, and 6 and 24 hours after telmisartan (or PBS) administration.
Autologous blood-injected ICH model
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Additional experiments were also performed using a direct infusion of autologous blood into the rat striatum as an alternative model (Chu et al., 2004; Lee ST et al., 2006) . A small craniotomy was performed using the same stereotactic coordinates and 300 µ L of autologous unheparinized blood (from the femoral artery) was infused into the left striatum. In this model, we analyzed the brain water content in the ICH-only group and ICH-TMS group (30 mg/kg) that were initially treated 2 h after ICH induction and verified whether the effects of telmisartan would be comparable with those in the collagenase-induced ICH models.
Behavioral Testing
To examine the effects of the telmisartan on the neurological deficits of rats after ICH, behavioral test was performed, by two investigators blinded to the treatment status of the rats, with modified limb placing tests (MLPT) (Chu et al., 2004; Jung et al., 2004; Lee et al., 2006) . The test consists of 2 limb-placing tasks that assess the sensorimotor integration of the forelimb and the hind limb by checking responses to tactile and proprioceptive stimulation. First, the rat is suspended 10 cm over a 
Hemorrhage volume and water content
Hemorrhage volume was quantified at 24 hours or 72 hours, via a spectrophotometric assay conducted as described previously (Lee et al., 2006) . Measurements from perfused brains subjected to ICH were compared with the standard curve, in order to obtain data in terms of hemorrhage volume (µL, n=6 per group). Seventy-two hours after the induction of ICH, the rats were anesthetized, sacrificed via decapitation and processed for measuring water content (n=6 per group) (Chu et al., 2004; Jung et al., 2004; Lee et al., 2006) . Water content was expressed as a percentage of wet weight.
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On day 3, the rats (n=6 per group) were re-anesthetized and perfused through the heart with 50 ml cold saline and 50 ml of 4% paraformaldehyde, in 0.1 mol/L PBS. We conducted immunostaining with antibodies against myeloperoxidase (MPO; 1:200, DAKO), and Ox-42 (1:500, chemicon), as previously described (Chu et al., 2004; Jung et al., 2004; Lee et al., 2006) . We also conducted a TUNEL procedure for the in situ detection of DNA fragmentation, as was described previously (Chu et al., 2004; Jung et al., 2004; Lee et al., 2006) . Coronal sections taken through the center of the needle insertion were analyzed via the counting of marker-specific cells throughout the entire section (3 sections per each antibody staining, 1 mm width). The total counts in these sections were converted to cell densities, in order to facilitate quantitation and comparison between the groups.
Western blotting
Twenty-four hours after the induction of ICH, the rats were sacrificed via decapitation, and the brains were immediately extracted (n=3 per group). Homogenates of the ipsilateral hemisphere were serially processed for western blotting, as described 
Measurement of Caspase Activities
Caspase activities were characterized with ELISA kits (Caspase-3: Promega, Caspase-8:
BD Biosciences, Caspase-9: Chemicon, n=3 per group), at 24 hours after the induction of ICH, as was previously described in other reports (Lee and Lo, 2003) . Fluorescent 
Evaluation of the oxidative stress
One day after reperfusion, the rat brains were processed for the analysis of oxidative stress (n=6 per group). The oxidative fluorescent dye dihydroethidium (DHE, SigmaAldrich) was used to evaluate in situ production of superoxide (Jung et al., 2006) . 13 mixture was cooled with tap water and 5 ml of n-butanol: pyridine (15:1) and 1 ml of distilled water was added. After centrifugation at 4000 rpm for 10 minutes, the organic layer was withdrawn and absorbance was measured at 532 nm using a spectrophotometer.
Statistical Analysis
All data in this study are presented as means ± standard deviations (SD). Data were analyzed by one-way analysis of variance (ANOVA) followed by Tukey's test (when appropriate) or student's t test if they were normally distributed (Kolmogorov-Smirov test, p>0.05). In the case of blood pressure and behavior data, values of different time points were compared by two-way repeated measures ANOVA. Without normal distribution, we used the Mann-Whitney U test.
RESULTS
Telmisartan prompted a functional recovery.
There were no significant differences in rectal temperature, arterial blood gases, and pH values among the experimental groups measured before and after ICH induction, and 6
and 24 hours after telmisartan (or PBS) administration. Post-ICH mean arterial pressure This article has not been copyedited and formatted. The final version may differ from this version. the ICH-only group at 1 day after the induction of ICH, and then continued to recover, with the difference between the two groups being statistically significant until at least 4 weeks after the induction of ICH (p<0.05, t-test). At week 4, the ICH-TMS group scored less than two points on the MLPT (Fig. 1a) .
Telmisartan reduced hemorrhage volume and brain water content.
Telmisartan treatment attenuated the hemorrhage volume by 63%, as compared with the ICH-only group, 1 day after the induction of ICH, and by 86% at 3 days after ICH. The hemorrhage volumes were as follows: 43.4 ± 4.5 
Telmisartan reduced inflammatory cell infiltration and apoptotic cells.
TUNEL staining revealed a high density of positively-stained cells within the hemorrhage lesions themselves, as well as in the periphery of the lesions (Fig. 2a) .
Quantitative analysis revealed differences between the groups with regard to the number Telmisartan downregulated the inflammatory and apoptotic molecules, combined with the upregulation of eNOS expression and PPARγ.
Western blotting revealed the upregulation of PPARγ and eNOS expression and the downregulation of COX2 induced by telmisartan treatment (Fig. 3a) . Analysis of the 52-kd band corresponding to PPARγ demonstrated a 1.6 (± 0.1) fold increase in nuclear extracts of hemorrhagic brain tissue at 24 hours after the onset of ICH (Fig. 3c) . The relative optical density of eNOS expression in the ICH-TMS group was 16.5 (± 1.2) times as high as in the ICH-only group (p<0.01, Mann-Whitney U test; Fig. 3d ).
Meanwhile, COX2 expression was significantly attenuated in the ICH-TMS group (35% decrease vs ICH-only group; p<0.01, Mann-Whitney U test; Fig.s 3e) . Caspase activities were significantly reduced in the ICH-TMS group. Twenty-four hours after the induction of ICH, caspase-3 activity in the ICH-TMS group was determined to be significantly lower than that of the ICH-only group (62% decrease; p<0.01, MannWhitney U test; Fig. 3f ). Caspase-8 and 9 activities were also shown to have been significantly reduced in the ICH-TMS group (31% decrease in caspase-8; 20 % decrease in caspase-9; p<0.01, t-test; Fig. 3f ). In the analysis for the Angiotensin II receptors, AT1 and AT2, both of the ICH groups manifested marked increases in the expression of 
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AT1 receptor mRNA after injury (3.5 fold increase: ICH-only; 3.1 folds increase: ICH-TMS), but exhibited no changes in the expression of the AT2 receptor ( Fig. 4a and b) .
We measured the mRNA expression of cytokine-related genes, including TNF-α, Fas, and FasL. The hemorrhagic brain samples expressed abundant amounts of mRNA of these molecules, whereas the normal brains expressed them only at very low levels.
Relative optical density analysis revealed the ICH-TMS group to have undergone a 94% decrease in the levels of TNF-α, a 56% decrease in Fas, and a 79% reduction in FasL mRNA levels, as compared with the ICH-only group (p<0.01, Mann-Whitney U test; Fig. 4c ).
Telmisartan reduced the oxidative stress in the hemorrhagic brain.
In the normal rats, few evidence of DHE-induced EtBr fluorescence was observed in the cortex and striatum. Superoxide-generating cells were increased in the hemorrhagic hemisphere, whereas only a few labeled cells were detected in the nonhemorrhagic hemisphere ( Fig. 5a-c) . Data from image analysis indicated that DHE-induced ethidium bromide fluorescence was 74% less pronounced in the ICH-TMS group than in the ICH-only group ( Fig. 5d; 
DISCUSSION
In this study, telmisartan was shown to attenuate hemorrhage expansion and perihematomal edema formation, to induce neuroprotection, and to enhance functional recovery. These effects of telmisartan were associated with the inhibition or amelioration of apoptosis, oxidative stress, and neuroinflammation, rather than blood pressure reduction. Oxidative stress during ICH is another critical event, which leads to the disruption of the BBB, combined with hematoma expansion and secondary vasogenic edema (Tang et al., 2005) . Angiotensin II is one of the most important known oxidative stress inducers, and produce reactive oxygen species by the enzyme NADPH oxidase (Berry et al., 2001; Cai et al., 2003) . The reduced levels of the superoxide and lipid peroxidation product by telmisartan might contribute to a remarkable reduction in the hematoma growth and edema.
Recent evidences suggest that PPARγ activation represents a novel mechanism
This article has not been copyedited and formatted. The final version may differ from this version. for the beneficial effects of ARBs (Benson et al., 2004; Schupp et al., 2004) .
Telmisartan can function as a partial agonist of PPARγ (Benson et al., 2004) . ARBs to improve the hostile environments of the hemorrhagic brain.
In conclusion, we provide convincing evidences to suggest that telmisartan does, RT-PCR results were analyzed in terms of the optical density ratio to the GAPDH (a).
AT1 was upregulated in the hemorrhagic compared with the normal samples, and this was also apparent in the ICH-TMS group (b). AT2, however, exhibited no changes.
Whereas the ICH-only group exhibited upregulations in TNF-alpha, Fas, and Fas-L, the ICH-TMS rats exhibited reduced expressions of all of these molecules (c). *p<0.05 vs normal in (b) and vs ICH-only in (c) (n=3, Mann-Whitney U test). 
